FDA Clears BD EnCor EnCompass Breast Biopsy System
FRANKLIN LAKES, New Jersey | January 19, 2026 — Becton, Dickinson and Company (BD) announced that the U.S. Food...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
FRANKLIN LAKES, New Jersey | January 19, 2026 — Becton, Dickinson and Company (BD) announced that the U.S. Food...
ROSWELL, Ga., December 29, 2025 — StimLabs has announced that the U.S. Food and Drug Administration (FDA) has granted...
VANCOUVER, British Columbia — December 16, 2025 — Zephyrus Innovations™, a privately owned medical device company focused on safety-engineered...
Grove City, Ohio – October 30, 2025 — Tosoh Bioscience, Inc., a global leader in clinical diagnostics and laboratory...
September 17, 2025 — The Hague, The Netherlands Amber Implants has received FDA 510(k) clearance for its VCFix® Spinal...
